X0202 SCHEDULE 13G 0001839919 XXXXXXXX LIVE Common Stock, par value $0.001 per share 03/27/2026 0001624326 PAVmed Inc. 70387R502 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 Rule 13d-1(c) Dols Scott V. X1 346155.00 0.00 346155.00 0.00 346155.00 5.4 IN PAVmed Inc. 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10017. This Schedule 13G is filed by Scott V. Dols ("Mr. Dols" or the "Reporting Person"). Any disclosures herein with respect to persons other than the Reporting Person are made on information and belief after making inquiry to the appropriate party. The filing of this Schedule 13G should not be construed in and of itself as an admission by the Reporting Person as to beneficial ownership of the shares of Common Stock reported herein. The principal business address of the Reporting Person is 19822 Wetherby Lane, Lutz, Florida 33549. The Reporting Person is a citizen of the United States. Y Mr. Dols beneficially owns 346,155 shares of Common Stock, including 230,770 shares held by a trust of which Mr. Dols is trustee. Mr. Dols may be deemed to beneficially own the shares of Common Stock held by the trust. Mr. Dols beneficially owns 5.4% of the outstanding shares of Common Stock. The percentage of beneficial ownership is calculated based on 6,383,089 shares of Common Stock outstanding as of March 27, 2026, as set forth in the Company's annual report on Form 10-K filed on March 27, 2026. 346,155 shares 0 shares 346,155 shares 0 shares Y N Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Dols Scott V. /s/ Scott V. Dols 04/08/2026